Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ARKO Corp. - Common Stock
(NQ:
ARKO
)
4.930
-0.110 (-2.18%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ARKO Corp. - Common Stock
< Previous
1
2
Next >
Arko (ARKO) Q3 2025 Earnings Call Transcript
↗
November 05, 2025
Arko (ARKO) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
ARKO Corp. (NASDAQ:ARKO) Q2 2025 Earnings: EPS Beats Estimates, Revenue Misses Amid Store Conversions
↗
August 06, 2025
ARKO Corp. (NASDAQ:ARKO) reported Q2 2025 earnings, beating EPS estimates at $0.16 but missing revenue at $1.999B. Adjusted EBITDA was $76.9M, with store conversions and share buybacks driving growth.
Via
Chartmill
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Thursday?
↗
February 27, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2024
↗
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Preview: ARKO's Earnings
↗
November 03, 2023
Via
Benzinga
ARKO: Dividend Insights
↗
August 09, 2023
Via
Benzinga
ARKO's Return On Capital Employed Overview
↗
May 23, 2023
Via
Benzinga
Which stocks are moving on Thursday?
↗
February 27, 2025
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Stifel Downgrades ARKO As Sales Struggle Amid Volatile Conditions
↗
February 27, 2025
Stifel analyst Mark Astrachan downgraded ARKO Corp (NASDAQ: ARKO) from Buy to Hold, reducing the price target to $7.5. ARKO's fourth-quarter results showed weaker-than-expected adjusted EBITDA and...
Via
Benzinga
These stocks are gapping in today's session
↗
February 27, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
December 31, 2024
Via
Benzinga
ARKO Boosts Share Buyback By $50M
↗
May 16, 2023
Via
Benzinga
ARKO Stock Earnings: ARKO Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
ARKO stock results show that ARKO beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Consumer Staples Stocks To Buy As Prices Slow Down
↗
July 04, 2024
The Consumer Staples sector has been going steady this year after declining for two years in a row. As of Jul 3, the S&P 500 Consumer Staples Select Sector SPDR was up 7.7%.
Via
Talk Markets
Topics
Stocks
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 08, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
↗
May 08, 2024
Via
Benzinga
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
↗
May 08, 2024
Via
Benzinga
ARKO Stock Earnings: ARKO Beats EPS, Misses Revenue for Q1 2024
↗
May 07, 2024
ARKO stock results show that ARKO beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
↗
April 11, 2024
Via
Benzinga
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session
↗
April 05, 2024
Via
Benzinga
Top 5 Consumer Stocks You'll Regret Missing This Quarter
↗
March 05, 2024
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
↗
February 28, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session
↗
May 19, 2023
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
↗
May 09, 2023
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today